Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study

被引:8
作者
Bahgat, Dina M. Rasheed [1 ]
Shahin, Rasha Mohamad Hosny [1 ]
Makar, Nada Nasr [1 ]
Aziz, Ashraf Omar Abdel [2 ]
Hunter, Shereen Shoukry [3 ]
机构
[1] Cairo Univ, Dept Clin Pathol, Kasr Al Ainy Hosp, Cairo 11431, Egypt
[2] Cairo Univ, Dept Trop Med & Hepatol, Kasr Al Ainy Hosp, Cairo 11431, Egypt
[3] Cairo Univ, Dept Endem Med, Kasr Al Ainy Hosp, Cairo 11431, Egypt
关键词
RECK; rs; 11788747; HCC; Egypt; MATRIX; INHIBITOR; REGULATOR;
D O I
10.1002/jcla.21806
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundThe reversion-inducing-cysteine-rich protein with kazal motifs (RECK) gene is a transformation suppressor gene that can negatively regulate matrix metalloproteinases (MMPs) and inhibit tumor invasion, angiogenesis, and metastasis. So, the aim of this study was to analyze the effect of RECK gene rs 11788747 single nucleotide polymorphism (SNP) on hepatocellular carcinoma (HCC) susceptibility and its relation to various clinical and laboratory data of the patients. MethodsThis is a case-control study including 200 HCC patients and 200 healthy controls. RECK rs 11788747 genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). ResultsRECK rs 11788747 A/G and G/G genotypes frequencies were significantly higher in HCC patients compared to the healthy controls. The HCC patients possessing at least one polymorphic G allele were significantly at a higher risk of developing lymph nodes involvement and distant metastasis. ConclusionThis study revealed the role of RECK rs 11788747 SNP in HCC in Egyptian patients, which consequently might be used as a prognostic tool and could be added to its therapeutic strategies.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 14 条
  • [1] MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer
    Bloomston, M
    Shafii, A
    Zervos, EE
    Rojiani, A
    Rosemurgy, AS
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 102 (01) : 35 - 38
  • [2] Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
    Chung, Tsung-Te
    Yeh, Chao-Bin
    Li, Yi-Ching
    Su, Shih-Chi
    Chien, Ming-Hsien
    Yang, Shun-Fa
    Hsieh, Yi-Hsien
    [J]. PLOS ONE, 2012, 7 (03):
  • [3] RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer
    Clark, Jonathan C. M.
    Thomas, David M.
    Choong, Peter F. M.
    Dass, Crispin R.
    [J]. CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 675 - 683
  • [4] Risk of HCC: Genetic heterogeneity and complex genetics
    Dragani, Tommaso A.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (02) : 252 - 257
  • [5] European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]
  • [6] Diagnosis of hepatocellular carcinoma
    Gomaa, Asmaa I.
    Khan, Shahid A.
    Leen, Edward L. S.
    Waked, Imam
    Taylor-Robinson, Simon D.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (11) : 1301 - 1314
  • [7] Meng N, 2008, HISTOL HISTOPATHOL, V23, P1003, DOI 10.14670/HH-23.1003
  • [8] Recklessness as a hallmark of aggressive cancer
    Noda, Makoto
    Takahashi, Chiaki
    [J]. CANCER SCIENCE, 2007, 98 (11): : 1659 - 1665
  • [9] The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
    Oh, J
    Takahashi, R
    Kondo, S
    Mizoguchi, A
    Adachi, E
    Sasahara, RM
    Nishimura, S
    Imamura, Y
    Kitayama, H
    Alexander, DB
    Ide, C
    Horan, TP
    Arakawa, T
    Yoshida, H
    Nishikawa, SI
    Itoh, Y
    Seiki, M
    Itohara, S
    Takahashi, C
    Noda, M
    [J]. CELL, 2001, 107 (06) : 789 - 800
  • [10] TRANSECTION OF ESOPHAGUS FOR BLEEDING ESOPHAGEAL VARICES
    PUGH, RNH
    MURRAYLY.IM
    DAWSON, JL
    PIETRONI, MC
    WILLIAMS, R
    [J]. BRITISH JOURNAL OF SURGERY, 1973, 60 (08) : 646 - 649